U.S. stock market quick update: Incannex Healthcare up 27.23%

U.S. Stock Market Midday Update Incannex Healthcare rose 27.23%. Based on recent important news: On August 22, Incannex Healthcare announced that its board approved a stock repurchase plan of up to $20 million, driving the stock price up 36.9%. On August 22, the company stated that the repurchase plan would be executed through open market purchases, reflecting its commitment to enhancing shareholder value. On August 22, Incannex Healthcare rose 31.6% in pre-market trading due to the market's positive response to its capital management strategy. Stocks with High Trading Volume in the Industry Eli Lilly rose 1.11%, with increased trading volume. Based on recent important news: On August 20, Eli Lilly announced that Anne White, Executive Vice President of Neuroscience, would retire, causing the stock price to drop 2.2%. On August 20, Eli Lilly received additional approvals for indications, including sleep apnea and MASH, driving the stock price up. On August 20, Deutsche Bank maintained a buy rating on Eli Lilly with a target price of $900. Novo Nordisk rose 3.54%, with increased trading volume. Based on recent important news: On August 19, Novo Nordisk announced that semaglutide was approved by the FDA for the treatment of fatty liver disease, causing the stock price to rise about 4%. On August 19, Novo Nordisk reduced the out-of-pocket price of its diabetes drug NovoTide in the U.S. to $499, with the stock price closing up over 6%. On August 20, the President of the China Council for the Promotion of International Trade met with the Chairman of Novo Nordisk's board to discuss expanding investments in China. Johnson & Johnson rose 0.78%, with increased trading volume. Based on recent important news: On August 21, Johnson & Johnson announced a $2 billion investment to expand its manufacturing capacity in the U.S. in response to potential drug import tariffs from the Trump administration, with the stock price rising 0.15%. On August 22, Citigroup raised its target price for Johnson & Johnson to $200, boosting market confidence. On August 21, Johnson & Johnson reached a cooperation agreement with Fujifilm to establish a new factory in North Carolina, further enhancing its domestic production layout. Stocks with High Market Capitalization in the Industry AstraZeneca rose 0.80%, with increased trading volume. Based on recent important news: On August 22, AstraZeneca announced that its durvalumab was approved domestically for the treatment of certain types of breast cancer, driving the stock price up 0.80%. On August 22, AstraZeneca established a research and development center in the Philippines, further consolidating its position in the Asian market. On August 13, AstraZeneca's acquisition of the Chinese business of Roche was granted unconditional approval, enhancing its business layout in the Chinese market